<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Exp Med</journal-id>
      <journal-title-group>
        <journal-title>Clinical and Experimental Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1591-8890</issn>
      <issn pub-type="epub">1591-9528</issn>
      <publisher>
        <publisher-name>Springer Milan</publisher-name>
        <publisher-loc>Milan</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3087108</article-id>
      <article-id pub-id-type="pmid">20953890</article-id>
      <article-id pub-id-type="publisher-id">113</article-id>
      <article-id pub-id-type="doi">10.1007/s10238-010-0113-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Glycosylation of mucins present in gastric juice: the effect of <italic>helicobacter pylori</italic> eradication treatment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Radziejewska</surname>
            <given-names>Iwona</given-names>
          </name>
          <address>
            <fax>+48-85-7485416</fax>
            <email>iwona@umwb.edu.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Borzym-Kluczyk</surname>
            <given-names>Ma&#x142;gorzata</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Namiot</surname>
            <given-names>Zbigniew</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stefa&#x144;ska</surname>
            <given-names>Ewa</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Medical Chemistry, Medical University of Bia&#x142;ystok, ul. Mickiewicza 2a, 15-222 Bia&#x142;ystok 8, Poland </aff>
        <aff id="Aff2"><label>2</label>Department of Pharmaceutical Biochemistry, Medical University of Bia&#x142;ystok, Bia&#x142;ystok, Poland </aff>
        <aff id="Aff3"><label>3</label>Department of Medicine and Gastroenterology, Regional Hospital of Bia&#x142;ystok, Bia&#x142;ystok, Poland </aff>
        <aff id="Aff4"><label>4</label>Department of Dietetics and Nutrition, Medical University of Bia&#x142;ystok, Bia&#x142;ystok, Poland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2011</year>
      </pub-date>
      <volume>11</volume>
      <issue>2</issue>
      <fpage>81</fpage>
      <lpage>88</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>3</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>9</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>It is suggested that gastric mucins, and in particular some specific glycan structures that can act as carbohydrate receptors, are involved in the interactions with <italic>Helicobacter pylori</italic> adhesins. The main aim of our study was to evaluate glycosylation pattern of glycoproteins of gastric juice before and at the end of eradication therapy. Gastric juices were taken from 13 clinical patients and subjected to analysis. Pooled fractions of the void volume obtained after gel filtration were subjected to ELISA tests. To assess the relative amounts of carbohydrate structures, lectins and monoclonal antibodies were used. Changes in the level of MUC 1 and MUC 5AC mucins and of carbohydrate structures, which are suggested to be receptors for <italic>Helicobacter pylori</italic> adhesins, were observed by the end of the eradication treatment. Our results support the idea about the involvement of MUC 5AC and MUC 1 with some specific sugar structures in the mechanism of <italic>Helicobacter pylori</italic> infection.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Gastric juices</kwd>
        <kwd>Glycosylation</kwd>
        <kwd>Lectins</kwd>
        <kwd>MUC 1 mucin</kwd>
        <kwd>MUC 5AC mucin</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>It is believed that gastric mucus gel layer forms an effective protective barrier against various pathogens, such as <italic>Helicobacter pylori</italic>, the major etiological agent of chronic gastritis, peptic ulcers, and gastric cancers [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. The main components of mucus are the heavily O-glycosylated proteins known as mucins. Three of them are present in human stomach. MUC 5AC and MUC 6 mucins are all secreted into gastric juice; the former being expressed by the surface epithelium and the latter by the deeper antrum gland epithelium [<xref ref-type="bibr" rid="CR4">4</xref>]. In addition, the epithelial membrane-associated MUC 1 mucin is also present in the stomach [<xref ref-type="bibr" rid="CR5">5</xref>]. The glycans in mucins are mainly O-linked with blood group antigens often present terminally. Mucin-type oligosaccharides are structurally very diverse; the glycans in the same molecule can exhibit a high degree of subtle variations in their structure depending on dynamic physiological and pathological biochemical conditions that exist in the body at the time when the structures are formed [<xref ref-type="bibr" rid="CR6">6</xref>]. The glycosyltransferases expressed by the individual determine glycan profiles of mucins in that individual [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
      <p><italic>Helicobacter pylori</italic> can colonize gastric epithelium by interactions with carbohydrates receptors [<xref ref-type="bibr" rid="CR8">8</xref>]. Lewis b structure is one of the known receptors for bacterial adhesins (BabA&#x2013;the blood group antigen&#x2013;binding adhesin), and it is considered that MUC 5AC mucin is the main carrier of this structure [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Some other glycoform structures (e. g. H type 1 structure, sialyl Lewis x) are also suggested to be implicated in binding with <italic>H. pylori</italic> adhesins [<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR12">12</xref>]. It has been recently proposed that apart from MUC 5AC mucin, also MUC 1 can be carrier of receptors for bacterial adhesins and can be involved in development of infection [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. There are suggestions that changes in glycoforms can affect the protective functions of gastric mucins and <italic>H. pylori</italic> colonization. It is postulated that alterations that occur during <italic>H. pylori</italic> infection are completely reversed after eradication [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>The main aim of our study was to check whether there are changes in the pattern of glycosylation of the mucins of gastric juice before and after eradication of <italic>H. pylori.</italic> We assumed that carbohydrates present in gastric juice originate from gastric mucosa. Among them, there are secreted MUC 5AC mucin and soluble form of membrane-bound MUC 1. We suppose a parallel relationship between MUC 1 cell membrane expression and its shedding to gastric juice. To test the changes in glycosylation, we used ELISA method with monoclonal antibodies against gastric mucins and some glycan epitopes and biotinylated lectins with well-known sugar specificity.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>Patients and specimens</title>
        <p>Thirteen <italic>Helicobacter pylori</italic>&#x2013;infected patients with duodenal ulcers (9 men, 4 women; age range 24&#x2013;60, mean age 44), hospitalized in the Department of Medicine and Gastroenterology of Regional Hospital of Bia&#x142;ystok, Poland, were included in the study. Each patient was treated for 2&#xA0;weeks with oral administration of omeprazole (2&#xA0;&#xD7;&#xA0;20&#xA0;mg per day), amoxiciline (2&#xA0;&#xD7;&#xA0;1,000&#xA0;mg), and tynidazole (2&#xA0;&#xD7;&#xA0;500&#xA0;mg). All subjects were on standard hospital diet served for the peptic ulcer patients. The tested gastric juices were taken before and on days 11&#x2013;13 of the treatment. They were collected by aspiration for 15&#xA0;min with a gastric catheter inserted through the nares. The procedure was performed in the morning hours after overnight fasting. At the first gastric test, no drugs were allowed for at least 14&#xA0;days, at the second gastric test the last doses of the drugs (omeprazole, amoxicillin, and tinidazole) were taken in the evening preceding the day of the examination.</p>
        <p>The presence of the bacterium was examined histologically and by urease test with gastric cells scraped under endoscopic examination. It was done before and at the end of the treatment. The eradication therapy was successful in all the patients at the second endoscopy assessment.</p>
      </sec>
      <sec id="Sec4">
        <title>Enzyme-linked immunosorbent assay</title>
        <p>The juice was initially treated as described before [<xref ref-type="bibr" rid="CR15">15</xref>]. High molecular mass material obtained in the void volume after gel filtration was subjected to further analysis. To assess relative amounts of carbohydrate structures in examined material, ELISA tests with monoclonal antibodies and biotinylated lectins were performed. Specifications of antibodies employed in this study are listed in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. For carbohydrate specificity of lectins, see Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>. Samples of gastric juices were diluted to the identical protein concentration 5 &#x3BC;g/mL, and aliquots (50 &#x3BC;L) were coated onto microtiter plates (NUNC F96; Maxisorp, Roskilde, Denmark) at room temperature overnight. The protein content was determined using bicinchoninic acid [<xref ref-type="bibr" rid="CR16">16</xref>]. The plates were washed 3 times (100 &#x3BC;L) with PBS, pH 7.4, 0.05% Tween (PBS-T; washing buffer) between all ensuing steps. Unbound sites were blocked with 100 &#x3BC;L of 1% blocking reagent for ELISA (Roche Diagnostics, Mannheim, Germany) for 1&#xA0;h. The microtiter plates were incubated with 100 &#x3BC;L of biotinylated lectins (1&#xA0;h) diluted to 0.5 &#x3BC;g/mL in PBS-T, 1% bovine serum albumin, BSA (Sigma, St Luis, MO, USA). Some lectin solutions were supplemented with metal cations: DSA, UEA, SNA, LTA, PNA, and GNA with 0.1&#xA0;mmol/L CaCl<sub>2</sub>; MAA and VVA with 0.1&#xA0;mmol/L CaCl<sub>2</sub> and 0.01&#xA0;mmol/L MnCl<sub>2</sub>. Plates were then incubated with 100 &#x3BC;L of horseradish peroxidase avidin D (Vector, Burlingame, CA, USA) (1 : 2 500) in PBS-T, 1% BSA for 1&#xA0;h. Next, plates were washed 4 times in PBS, and the colored reaction was developed by incubating with 2,2&#x2032;-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS)&#x2013;liquid substrate for horseradish peroxidase (Sigma, St Luis, MO, USA). Absorbance at 405&#xA0;nm was measured after 30&#x2013;45&#xA0;min. For analysis with monoclonal antibodies (diluted in washing buffer, 1% BSA), the plates were coated with 100 &#x3BC;L of antibody for 1&#xA0;h. Next, they were incubated with secondary antibody, horseradish peroxidase&#x2013;conjugated anti-mouse IgG (for anti-MUC 1, MUC 5AC, Lewis b, and H type 1 structures) or anti-mouse IgM (for anti-sialyl Lewis x structure). The colored reaction was developed as mentioned earlier. As controls wells with no gastric juices were used.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Sources of antibodies used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Antibody</th><th align="left">Clone</th><th align="left">Source</th><th align="left">Final dilution</th></tr></thead><tbody><tr><td align="left">MUC 1 (anti-human episialin&#x2013;EMA)</td><td align="left">GP1.4</td><td align="left">SIGMA</td><td align="left">1:400</td></tr><tr><td align="left">MUC 5AC</td><td align="left">45M1</td><td align="left">SIGMA</td><td align="left">1:400</td></tr><tr><td align="left">Lewis b</td><td align="left">LWB01</td><td align="left">LAB VISION</td><td align="left">1:1,500</td></tr><tr><td align="left">Sialyl Lewis x</td><td align="left">KM93</td><td align="left">CHEMICON</td><td align="left">1:500</td></tr><tr><td align="left">H type 1</td><td align="left">17-206</td><td align="left">ABCAM</td><td align="left">1:500</td></tr><tr><td align="left">Horseradish peroxidase&#x2013;conjugated rabbit anti-mouse IgG</td><td align="left"/><td align="left">SIGMA</td><td align="left">1:1,500</td></tr><tr><td align="left">Horseradish peroxidase&#x2013;conjugated goat anti-mouse IgM (&#x3BC;-chain specific)</td><td align="left"/><td align="left">SIGMA</td><td align="left">1:1,500</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>The major binding specificities of used lectins</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Origin and used abbreviation of lectin </th><th align="left">Binding preference</th></tr></thead><tbody><tr><td align="left"><italic>Areulia auranta</italic> (AAA)</td><td align="left">Fuc&#x3B1;1-6GlcNAc; Fuc&#x3B1;1-2Gal; Fuc&#x3B1;1-3GlcNAc [<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td align="left"><italic>Ulex europaeus</italic> (UEA)</td><td align="left">Fuc&#x3B1;1-2Gal; Fuc&#x3B1;1-3GlcNAc [<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td align="left"><italic>Lotus tetragonolobus</italic> (LTA)</td><td align="left">Fuc&#x3B1;1-3GlcNAc [<xref ref-type="bibr" rid="CR27">27</xref>]</td></tr><tr><td align="left"><italic>Maackia amurensis</italic> (MAA)</td><td align="left">NeuAc&#x3B1;2-3Gal [<xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td align="left"><italic>Sambucus nigra</italic> (SNA)</td><td align="left">NeuAc&#x3B1;2-6Gal/GalNAc [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td align="left"><italic>Arachis hypogaea</italic> (Peanut) (PNA)</td><td align="left">Gal&#x3B2;1-3GalNAc (T-antigen) [<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left"><italic>Vicia villosa</italic> (VVA)</td><td align="left">GalNAc (Tn-antigen) [<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td align="left"><italic>Datura stramonium</italic> (DSA)</td><td align="left">Gal&#x3B2;1-4GlcNAc; GlcNAc [<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td align="left"><italic>Narcissus pseudonarcissus</italic> (NPA)</td><td align="left">&#x3B1;-1,6 mannose residues [<xref ref-type="bibr" rid="CR33">33</xref>]</td></tr><tr><td align="left"><italic>Galanthus nivalis</italic> (GNA)</td><td align="left">&#x3B1;-1,3 mannose residues [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Statistical analyses</title>
        <p>The relative amounts of examined structures (based on absorbance at 405&#xA0;nm obtained from ELISA tests) were subjected to statistical analysis (by STATISTICA 7.1 StatSoft program). All the data revealed normal distribution, and two-sided <italic>t</italic>-test was used. Statistical significance was assumed at <italic>P</italic>&#xA0;&lt;&#xA0;0.05. Pearson&#x2019;s correlations of two variables (the relative amounts of MUC 1 and MUC 5AC mucins before and at the end of the treatment versus the relative amounts of examined carbohydrate structures before and at the end of the therapy) were calculated.</p>
        <p>The study was approved by the Institutional Ethical Committee and conducted according to the principles of the Declaration of Helsinki. Informed consent was obtained from all the patients.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Results</title>
      <p>Juices from 13 patients were divided into two groups: before eradication and at the end of eradication therapy (11&#x2013;13&#xA0;day of the treatment). High molecular mass material of void volume obtained after gel filtration of gastric juices was taken for glycan analysis.</p>
      <p>Glycans of all gastric juices examined revealed reactivity with monoclonal antibodies (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) and lectins (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) employed in this study. The analysis of the interactions of gastric juices with specific anti-MUC 1 and MUC 5AC monoclonal antibodies revealed higher levels of both mucins in juices at the end of eradication treatment. In case of MUC 1, the difference was statistically significant (<italic>P</italic>&#xA0;=&#xA0;0.000066) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Reactivity with monoclonal antibodies (at 405&#xA0;nm). <bold>a</bold> juices before eradication treatment (<italic>n</italic>&#xA0;=&#xA0;13); <bold>b</bold> juices at the end of eradication therapy (<italic>n</italic>&#xA0;=&#xA0;13). The points are connected for those that belong to the same sample</p></caption><graphic xlink:href="10238_2010_113_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Reactivity with lectins (at 405&#xA0;nm). <bold>a</bold> juices before eradication treatment (<italic>n</italic>&#xA0;=&#xA0;13); <bold>b</bold> juices at the end of eradication therapy (<italic>n</italic>&#xA0;=&#xA0;13). The points are connected for those that belong to the same sample</p></caption><graphic xlink:href="10238_2010_113_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Comparison of reactivity with monoclonal antibodies in juices before and the end of eradication therapy. <italic>Bars</italic> represent the mean&#xA0;&#xB1;&#xA0;SD</p></caption><graphic xlink:href="10238_2010_113_Fig3_HTML" id="MO3"/></fig></p>
      <p>The relative amounts of specific carbohydrate structures Lewis b, sialyl Lewis x, and H type 1 recognized by monoclonal antibodies were found to be higher at the end of eradication therapy. For sialyl Lewis x and H type 1 structures, the differences were statistically significant (<italic>P</italic>&#xA0;=&#xA0;0,00208 and 0.00209 for sialyl Lewis x and H type 1, respectively) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>).</p>
      <p>Fucosylation profile was examined by LTA, UEA, and AAA lectins. The lowest amount was observed for Fuc &#x3B1; 1-3 bond. The relative amounts of all fucosylated structures were higher at the end of eradication treatment. The differences were statistically significant for AAA and UEA lectins (<italic>P</italic>&#xA0;=&#xA0;0.000124 and 0.03475, respectively) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Comparison of reactivity with lectins in juices before and the end of eradication therapy. <italic>Bars</italic> represent the mean&#xA0;&#xB1;&#xA0;SD</p></caption><graphic xlink:href="10238_2010_113_Fig4_HTML" id="MO4"/></fig></p>
      <p>SNA and MAA are lectins specific for sialic acid. The analysis of interactions of these lectins with glycoproteins of juices showed a little higher amount of SA &#x3B1; 2&#x2013;3 than SA &#x3B1; 2&#x2013;6 linkage. In both cases, higher level of these specific structures was observed at the end of the treatment with statistically significant difference for SNA (<italic>P</italic>&#xA0;=&#xA0;0.003475) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).</p>
      <p>PNA and VVA lectins recognize T and Tn antigens, respectively. The results of our analyses revealed almost the same level of binding of both lectins to glycans present in two examined groups of juices (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).</p>
      <p>The relative amounts of complexes formed between sugar structures of gastric juices and DSA lectin (specific for Gal &#x3B2; 1&#x2013;4 GlcNAc-R and GlcNAc-R linkages) were significantly higher after eradication treatment (<italic>P</italic>&#xA0;=&#xA0;0.011) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).</p>
      <p>NPA and GNA are lectins with specificity toward &#x3B1; 1&#x2013;6 and &#x3B1; 1&#x2013;3 linked mannose, present especially in N-glycoproteins. The relative amounts of above linkages were low in comparison with bonds revealed by other lectins, with very similar level before and at the end of eradication treatment (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).</p>
      <p>Pearson&#x2019;s correlations between the amounts of examined sugar structures and the amounts of MUC 5AC and MUC 1 mucins in juices before treatment and at the end of eradication therapy were calculated. Mostly, the correlations between mentioned structures in two examined groups of juices were rather low. Moderate and high correlations in both groups of juices were found between the amounts of MUC 1 and H type 1 structure (<italic>r</italic>&#xA0;=&#xA0;0.39 and 0.87 for juice before and at the end of the treatment, respectively). Such positive correlations were also revealed between MUC 5AC and structure recognized by SNA lectin (<italic>r</italic>&#xA0;=&#xA0;0.47 and 0.46 for juice before and at the end of the treatment) and between MUC 5AC and structure recognized by LTA and UEA lectins (<italic>r</italic>&#xA0;=&#xA0;0.8 and 0.48 for LTA and 0.39 and 0.32 for UEA for juice before and at the end of the eradication therapy, respectively). In case of MUC 5AC and Lewis b structure, correlations were also positive in both juices (<italic>r</italic>&#xA0;=&#xA0;0.27 and 0.46). The values of all coefficients together with their statistical significances are summarized in Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>.<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Pearson&#x2019;s coefficients calculated for two variables (the relative amounts of MUC 1 and MUC 5AC mucins before and at the end of the treatment versus the relative amounts of examined carbohydrate structures before and at the end of the therapy)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left" colspan="2">Pearson&#x2019;s coefficient (<italic>r</italic>)</th></tr><tr><th align="left"/><th align="left"/><th align="left">Juices before eradication treatment</th><th align="left">Juices at the end of eradication treatment</th></tr></thead><tbody><tr><td align="left" rowspan="6">MUC 1 vs.</td><td align="left">Lewis b</td><td char="." align="char">0.44*</td><td char="." align="char">0.18*</td></tr><tr><td align="left">sialyl Lewis x</td><td char="." align="char">0.75*</td><td char="." align="char">&#x2212;0.07*</td></tr><tr><td align="left">H type 1</td><td char="." align="char">0.39</td><td char="." align="char">0.87*</td></tr><tr><td align="left">Structure recognized by MAA</td><td char="." align="char">&#x2212;0.11*</td><td char="." align="char">&#x2212;0.74*</td></tr><tr><td align="left">Structure recognized by SNA</td><td char="." align="char">0.3*</td><td char="." align="char">0.13</td></tr><tr><td align="left">Structure recognized by AAA</td><td char="." align="char">0.18*</td><td char="." align="char">0.17*</td></tr><tr><td align="left" rowspan="7"/><td align="left">Structure recognized by UEA</td><td char="." align="char">0.23*</td><td char="." align="char">0.31*</td></tr><tr><td align="left">Structure recognized by LTA</td><td char="." align="char">0.55*</td><td char="." align="char">&#x2212;0.14</td></tr><tr><td align="left">Structure recognized by PNA</td><td char="." align="char">&#x2212;0.24*</td><td char="." align="char">&#x2212;0.46*</td></tr><tr><td align="left">Structure recognized by VVA</td><td char="." align="char">&#x2212;0.37*</td><td char="." align="char">&#x2212;0.48*</td></tr><tr><td align="left">Structure recognized by DSA</td><td char="." align="char">0.11*</td><td char="." align="char">&#x2212;0.4</td></tr><tr><td align="left">Structure recognized by NPA</td><td char="." align="char">0.49</td><td char="." align="char">&#x2212;0.32*</td></tr><tr><td align="left">Structure recognized by GNA</td><td char="." align="char">0.62</td><td char="." align="char">&#x2212;0.26</td></tr><tr><td align="left" rowspan="13">MUC 5AC vs.</td><td align="left">Lewis b</td><td char="." align="char">0.27*</td><td char="." align="char">0.46*</td></tr><tr><td align="left">sialyl Lewis x</td><td char="." align="char">0.46</td><td char="." align="char">0.011*</td></tr><tr><td align="left">H type 1</td><td char="." align="char">0.5*</td><td char="." align="char">0.13</td></tr><tr><td align="left">Structure recognized by MAA</td><td char="." align="char">0.66*</td><td char="." align="char">&#x2212;0.13*</td></tr><tr><td align="left">Structure recognized by SNA</td><td char="." align="char">0.47</td><td char="." align="char">0.46</td></tr><tr><td align="left">Structure recognized by AAA</td><td char="." align="char">&#x2212;0.3*</td><td char="." align="char">&#x2212;0.16*</td></tr><tr><td align="left">Structure recognized by UEA</td><td char="." align="char">0.39*</td><td char="." align="char">0.32*</td></tr><tr><td align="left">Structure recognized by LTA</td><td char="." align="char">0.8</td><td char="." align="char">0.48</td></tr><tr><td align="left">Structure recognized by PNA</td><td char="." align="char">&#x2212;0.26*</td><td char="." align="char">0.033*</td></tr><tr><td align="left">Structure recognized by VVA</td><td char="." align="char">0.18*</td><td char="." align="char">0.16*</td></tr><tr><td align="left">Structure recognized by DSA</td><td char="." align="char">0.005</td><td char="." align="char">&#x2212;0.26</td></tr><tr><td align="left">Structure recognized by NPA</td><td char="." align="char">&#x2212;0.2</td><td char="." align="char">&#x2212;0.3*</td></tr><tr><td align="left">Structure recognized by GNA</td><td char="." align="char">0.24</td><td char="." align="char">&#x2212;0.28</td></tr></tbody></table><table-wrap-foot><p>Degrees of correlations: Pearson&#x2019;s coefficient <italic>r</italic>&#xA0;=&#xA0;1&#x2014;perfect correlation; 0.75&#xA0;&#x2264;&#xA0;<italic>r</italic>&#xA0;&lt;&#xA0;1&#x2014;high degree of correlation; 0.25&#xA0;&#x2264;&#xA0;<italic>r</italic>&#xA0;&lt;&#xA0;0.75&#x2014;moderate degree of correlation; 0&#xA0;&lt;&#xA0;<italic>r</italic>&#xA0;&lt;&#xA0;0.25&#x2014;low degree of correlation; &#x2212;1&#xA0;&#x2264;&#xA0;<italic>r</italic>&#xA0;&#x2264;&#xA0;0&#x2014;no correlation</p><p>*&#xA0;Denotes statistically significant differences (<italic>P</italic>&#xA0;&lt;&#xA0;0.05)</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec7">
      <title>Discussion</title>
      <p>Analyses of carbohydrates of gastric juices before and at the end of eradication therapy revealed alterations caused likely by <italic>H. pylori</italic> infection. Because the examined material was taken from the void volume after gel filtration, we assume that analyzed structures originate mostly from high molecular mass mucins. Two mucins, MUC 1 and MUC 5AC, which are suggested to be involved in the mechanism of the infection, were analyzed. MUC 5AC is secretory one and can be normally present in gastric juice. MUC 1 is membrane-bound mucin, but it can be cleaved by host cell proteases and released to juice from gastric cell surface [<xref ref-type="bibr" rid="CR17">17</xref>]. The higher level of both mucins was observed at the end of the treatment, which is in accordance with the results of some other investigations which revealed that <italic>H. pylori</italic> inhibits total mucin synthesis in gastric epithelial cells [<xref ref-type="bibr" rid="CR18">18</xref>&#x2013;<xref ref-type="bibr" rid="CR20">20</xref>]. It is suggested that protective ability of gastric mucins may depend largely on their oligosaccharide chains. Alterations in the glycosylation pattern induced by the infection can impair the protective function of mucins. An increased level of MUC 1 mucin after eradication treatment was also observed in our earlier investigations when we examined this structure and also Lewis b and a blood group antigens using Western blotting and densitometry [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p>Our results revealed increased level at the end of eradication therapy for only of those carbohydrate structures that are proposed to be involved in the interactions with <italic>H. pylori</italic> adhesins. The expression of fucosylated glycans was examined by anti-Lewis b, anti-H type 1 monoclonal antibodies, and AAA, UEA, and LTA lectins. Fuc &#x3B1; 1&#x2013;2 linkage, which seems to be the most abundant, is present especially in peripheral Gal residues, which can be easily available for bacterial adhesins. Fuc &#x3B1; 1&#x2013;2 bond is present in Lewis b and H type 1 structures, and these glycans were also observed in higher level at the end of the treatment. Therefore, our results support hypothesis about involvement of Lewis b and H type 1 structures in interactions with <italic>H. pylori</italic> [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The depletion of these antigens in the infectious state might promote infection by enhancing the access of the bacterium to the epithelial surface [<xref ref-type="bibr" rid="CR18">18</xref>]. Another explanation can also be taken into account. The decreased level of these possible bacterial receptors that can be located in MUC 1 and MUC 5AC mucin is suggested to be a kind of host defense. Some authors propose hypothesis with MUC 1 as a releasable decoy ligand for <italic>H.</italic> pylori that can be released from cell surface together with the adhered bacterium [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Carbohydrate structures of MUC 1 mucin that possess long filamentous extracellular domain are considered to be the point of first direct contact between host cells and pathogenic organisms that penetrate the secreted mucus layer.</p>
      <p>It is said that sialylated glycan structures are not typical for gastric mucins; they account for only about 3% of the total oligosaccharides (present in MUC 5AC mucin) [<xref ref-type="bibr" rid="CR18">18</xref>], but they are also considered by some authors as potential receptors for bacterial adhesins [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Sialylated forms are characteristic in <italic>H. pylori</italic>&#x2013;infected specimens, and they decrease after eradication [<xref ref-type="bibr" rid="CR10">10</xref>]. Surprisingly, in our study for both examined kinds of linkages, SA &#x3B1; 2&#x2013;3 and SA &#x3B1; 2&#x2013;6, the increased level in the recovered state was revealed. It is likely that high level of sialylation is due to the presence of highly sialylated, salivary MUC 5B mucin in gastric juice [<xref ref-type="bibr" rid="CR22">22</xref>]. However, it was not explored in our study. The increase in sialyl Lewis x structure (with &#x3B1; SA 2&#x2013;3 bond; recognized by monoclonal antibody) at the end of eradication therapy was significantly higher than that for SA &#x3B1; 2&#x2013;3 bond detected by MAA lectin. This discrepancy can be explained by higher specificity of monoclonal antibodies than lectins during detection. Sialylation through &#x3B1; 2&#x2013;6 bond is typical especially for short core carbohydrate structures and in our experiments was detected in low level, although with slight increase at the end of the therapy.</p>
      <p>Gal &#x3B2; 1-4 GlcNAc structure (detected by DSA lectin), typical for O-glycosylated mucins, found also in sialyl Lewis x glycoform, was more abundant at the end of eradication treatment. This result is in accordance with general tendency of the increased level of examined mucins and glycoforms involved in interactions with <italic>H. pylori</italic> at the end of the treatment.</p>
      <p>We observed no influence of the infection on the levels of short Tn and T carbohydrate structures. This result confirms the proposal that <italic>H. pylori</italic> influences only the peripheral sugar structures. Mannose residues, not typical in O-glycosidic chains, were detected in very low levels. These probably originate from rare N-glycosidic oligosaccharides that can be present in mucins [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>As the mechanism of <italic>H. pylori</italic> infection has not been elucidated thoroughly, it is difficult to explain the mechanism of alterations induced by the bacterium. One possible explanation is that <italic>H. pylori</italic> can change the expression of genes involved in glycan synthesis such as transferases, crucial for the biosynthesis of potential bacterial receptors [<xref ref-type="bibr" rid="CR18">18</xref>]. Interesting hypothesis about kind of relationship between two mucins (MUC 5AC and MUC 1) likely involved in the mechanism of infection has been proposed. MUC 5AC as more abundant one may at first catch <italic>Helicobacter pylori</italic> and then deliver it to the membrane-associated MUC 1 mucin. This mucin can cause signal transduction over the epithelial barrier and act as a releasable decoy. In this way, mucins together with the bacterium can be flushed away (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. The level of both mucins, with some specific sugar structures, acting as receptors for bacterial adhesins, decreases. These alterations are completely reversed after eradication [<xref ref-type="bibr" rid="CR14">14</xref>].<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Schematic illustration of the suggested sequence of events leading to changes occurring during <italic>Helicobacter pylori</italic> infection</p></caption><graphic xlink:href="10238_2010_113_Fig5_HTML" id="MO5"/></fig></p>
      <p>The influence of omeprazole alone on examined structures also cannot be excluded. It is said that pH change (after omeprazole treatment) in <italic>Helicobacter pylori</italic> environment can result in its affinity to mucins, and bacteria cannot remain efficiently bound to mucus and are flushed away [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. However, this was not examined in the present study.</p>
      <p>From our results, we are not able to tell which of the glycan epitopes are present in which mucin. We can only suggest that H type 1 structure comes mostly from MUC 1 mucin as correlations between them in both groups of patients examined were positive (on moderate and high level). Similar assumptions can be taken for MUC 5 AC and Lewis b, SA &#x3B1; 2&#x2013;6, Fuc &#x3B1; 1&#x2013;3, and &#x3B1; 1&#x2013;2 linkages because of positive values of Pearson&#x2019;s coefficients. However, we should emphasize that above sugar structures can be also present in other glycoproteins not examined in this study. So we state that our concepts should be supported by more detailed examinations.</p>
      <p>In conclusion, the observed changes in glycosylation pattern induced by <italic>H. pylori</italic> support the idea about the involvement of mucins and other glycan structures in the mechanism of the infection. We suggest that the knowledge about the exact action of the bacterium could contribute to looking for new therapeutic strategies.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p content-type="acknowledgment"><bold>Conflict of interest</bold> None.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corfield</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Myerscough</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Longman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sylvester</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Arul</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pignatelli</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease</article-title>
          <source>Gut</source>
          <year>2000</year>
          <volume>47</volume>
          <fpage>589</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="doi">10.1136/gut.47.4.589</pub-id>
          <pub-id pub-id-type="pmid">10986224</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uemura</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Helicobacter pylori</italic> infection and the development of gastric cancer</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>784</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa001999</pub-id>
          <pub-id pub-id-type="pmid">11556297</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Karlsson</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Korolik</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>McGuckin</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Mucins in the mucosal barrier to infection</article-title>
          <source>Mucosal Immunol</source>
          <year>2008</year>
          <volume>1</volume>
          <fpage>183</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="doi">10.1038/mi.2008.5</pub-id>
          <pub-id pub-id-type="pmid">19079178</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nordman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Lindell</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bolos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Real</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Carlstedt</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Gastric MUC 5AC and MUC 6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution</article-title>
          <source>Biochem J</source>
          <year>2002</year>
          <volume>364</volume>
          <fpage>191</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">11988092</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gendler</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>MUC 1, the renaissance molecule</article-title>
          <source>J Mammary Gland Biol Neoplasia</source>
          <year>2001</year>
          <volume>6</volume>
          <fpage>339</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1011379725811</pub-id>
          <pub-id pub-id-type="pmid">11547902</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orczyk-Pawi&#x142;owicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Floria&#x144;ski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zalewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>K&#x105;tnik-Prastowska</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Relative amounts of sialic acid and fucose of amniotic fluid glycoconjugates in relation to pregnancy age</article-title>
          <source>Glycoconjugate J</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>433</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="doi">10.1007/s10719-005-4437-5</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mahdavi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hedenbro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Boren</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Carlstedt</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Effects of pH on <italic>Helicobacter pylori</italic> binding to human gastric mucins; identification of binding to non-MUC 5AC mucins</article-title>
          <source>Biochem J</source>
          <year>2004</year>
          <volume>384</volume>
          <fpage>263</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="doi">10.1042/BJ20040402</pub-id>
          <pub-id pub-id-type="pmid">15260802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bovenkamp</surname>
              <given-names>JHB</given-names>
            </name>
            <name>
              <surname>Mahdavi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Korteland-Van Male</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The MUC 5AC glycoprotein is the primary receptor for <italic>Helicobacter pylori</italic> in the human stomach</article-title>
          <source>Helicobacter</source>
          <year>2003</year>
          <volume>8</volume>
          <fpage>521</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1523-5378.2003.00173.x</pub-id>
          <pub-id pub-id-type="pmid">14535999</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nordman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hedenbro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hurtig</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boren</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Carlstedt</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Strain- and blood group&#x2014;dependent binding of <italic>Helicobacter pylori</italic> to human gastric MUC 5AC glycoforms</article-title>
          <source>Gastroenterology</source>
          <year>2002</year>
          <volume>123</volume>
          <fpage>1923</fpage>
          <lpage>1930</lpage>
          <pub-id pub-id-type="doi">10.1053/gast.2002.37076</pub-id>
          <pub-id pub-id-type="pmid">12454849</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahdavi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sonden</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hurtig</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Helicobacter pylori</italic> SabA adhesin in persistent infection and chronic inflammation</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>297</volume>
          <fpage>573</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1069076</pub-id>
          <pub-id pub-id-type="pmid">12142529</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ilver</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Arnaqvist</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>&#x150;rgen</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Helicobacter pylori</italic> adhesin binding fucosylated histo-blood group antigens revealed by retagging</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>279</volume>
          <fpage>373</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="doi">10.1126/science.279.5349.373</pub-id>
          <pub-id pub-id-type="pmid">9430586</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheu</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Odenbreit</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>KH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interaction between host gastric sialyl-Lewis x and <italic>H. pylori</italic> SabA enhances <italic>H. pylori</italic> density in patients lacking gastric Lewis b antigen</article-title>
          <source>Am J Gastroenterol</source>
          <year>2006</year>
          <volume>101</volume>
          <fpage>36</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1572-0241.2006.00358.x</pub-id>
          <pub-id pub-id-type="pmid">16405531</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGuckin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Every</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Skene</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Linden</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Muc 1 mucin limits both <italic>Helicobacter pylori</italic> colonization of the murine gastric mucosa and associated gastritis</article-title>
          <source>Gastroenterology</source>
          <year>2007</year>
          <volume>133</volume>
          <fpage>1210</fpage>
          <lpage>1218</lpage>
          <pub-id pub-id-type="doi">10.1053/j.gastro.2007.07.003</pub-id>
          <pub-id pub-id-type="pmid">17919495</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ota</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Momose</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Helicobacter pylori</italic> infection produces reversible glycosylation changes to gastric mucins</article-title>
          <source>Virchows Arch</source>
          <year>1998</year>
          <volume>433</volume>
          <fpage>419</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="doi">10.1007/s004280050269</pub-id>
          <pub-id pub-id-type="pmid">9849856</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radziejewska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Borzym-Kluczyk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kisiel</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Namiot</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wosek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gindzie&#x144;ski</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The effect of <italic>Helicobacter pylori</italic> eradication tratment on the MUC 1 and Lewis antigens level in human gastric juice: a preliminary study</article-title>
          <source>Dig Dis Sci</source>
          <year>2008</year>
          <volume>53</volume>
          <fpage>2641</fpage>
          <lpage>2645</lpage>
          <pub-id pub-id-type="doi">10.1007/s10620-008-0224-z</pub-id>
          <pub-id pub-id-type="pmid">18409003</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Krohn</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Hermanson</surname>
              <given-names>GT</given-names>
            </name>
          </person-group>
          <article-title>Measurement of protein using bicinchoninic acid</article-title>
          <source>Anal Chem</source>
          <year>1985</year>
          <volume>150</volume>
          <fpage>76</fpage>
          <lpage>85</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanisch</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>MUC 1: the polymorphic appearance of human mucin</article-title>
          <source>Glycobiology</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>439</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="doi">10.1093/glycob/10.5.439</pub-id>
          <pub-id pub-id-type="pmid">10764832</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooke</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>An</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with <italic>Helicobacter pylori</italic></article-title>
          <source>Gastroenterology</source>
          <year>2009</year>
          <volume>137</volume>
          <fpage>1061</fpage>
          <lpage>1071</lpage>
          <pub-id pub-id-type="doi">10.1053/j.gastro.2009.04.014</pub-id>
          <pub-id pub-id-type="pmid">19375420</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Byrd</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Yunker</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Q-S</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Bresalier</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of gastric mucin synthesis by <italic>Helicobacter pylori</italic></article-title>
          <source>Gastroenterology</source>
          <year>2000</year>
          <volume>118</volume>
          <fpage>1072</fpage>
          <lpage>1079</lpage>
          <pub-id pub-id-type="doi">10.1016/S0016-5085(00)70360-X</pub-id>
          <pub-id pub-id-type="pmid">10833482</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kocer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ustundag</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A confirmatory report for the close interaction of <italic>Helicobacter pylori</italic> with gastric epithelial MUC 5AC expression</article-title>
          <source>J Clin Gastroenterol</source>
          <year>2004</year>
          <volume>38</volume>
          <fpage>496</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1097/01.mcg.0000123168.86324.1b</pub-id>
          <pub-id pub-id-type="pmid">15220684</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radziejewska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kisiel</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Borzym-Kluczyk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kluz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Namiot</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Gindzie&#x144;ski</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>MUC 1 mucin kontent in gastric juice of duodenal ulcer patients: effect of <italic>Helicobacter pylori</italic> eradication therapy</article-title>
          <source>Clin Exp Med</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>72</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1007/s10238-007-0128-9</pub-id>
          <pub-id pub-id-type="pmid">17609879</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wickstrom</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lindell</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>K</surname>
              <given-names>Gilshenan</given-names>
            </name>
            <name>
              <surname>Carlstedt</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Four models of adhesion are used during <italic>Helicobacter pylori</italic> binding to human mucins in the oral and gastric niches</article-title>
          <source>Helicobacter</source>
          <year>2008</year>
          <volume>13</volume>
          <fpage>81</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1523-5378.2008.00587.x</pub-id>
          <pub-id pub-id-type="pmid">18321298</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Every</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MUC 1 limits <italic>Helicobacter pylori</italic> infection both by steric hindrance and by acting as releasable decoy</article-title>
          <source>PLoS Pathog</source>
          <year>2009</year>
          <volume>5</volume>
          <fpage>e1000617</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.ppat.1000617</pub-id>
          <pub-id pub-id-type="pmid">19816567</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radziejewska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gindzie&#x144;ski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wosek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ko&#x17C;uszy&#x144;ska-Top&#xF3;r</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Namiot</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>The influence of omeprazole treatment on MUC 1 mucin contents in gastric juice of <italic>Helicobacter pylori</italic> infected patients</article-title>
          <source>Gastroenterol Pol</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>435</fpage>
          <lpage>438</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kochibe</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohkura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kobata</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Fractionation of L-fucose-containing oligosaccharides on immobilized <italic>Aleuria auranta</italic> lectin</article-title>
          <source>J Biol Chem</source>
          <year>1985</year>
          <volume>260</volume>
          <fpage>4688</fpage>
          <lpage>4693</lpage>
          <pub-id pub-id-type="pmid">3988732</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Audette</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Vandonselaar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Delbaere</surname>
              <given-names>LTJ</given-names>
            </name>
          </person-group>
          <article-title>The 2.2 &#xC5; resolution structure of the O(H) blood-group-specific Lectin I from <italic>Ulex europaeus</italic></article-title>
          <source>J Mol Biol</source>
          <year>2000</year>
          <volume>304</volume>
          <fpage>423</fpage>
          <lpage>433</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.2000.4214</pub-id>
          <pub-id pub-id-type="pmid">11090284</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wilkins</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Alvarez-Manilla</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Do</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Immobilized <italic>Lotus tetragonolobus</italic> agglutinin binds oligosaccharides containing the Le<sup>x</sup> determinant</article-title>
          <source>Glycoconjugate J</source>
          <year>1997</year>
          <volume>14</volume>
          <fpage>45</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1018508914551</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2, 3 to penultimate galactose residues</article-title>
          <source>J Biol Chem</source>
          <year>1988</year>
          <volume>263</volume>
          <fpage>4576</fpage>
          <lpage>4585</lpage>
          <pub-id pub-id-type="pmid">3350806</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shibuya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Broekaert</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Nsimba-Lubaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Peeters</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Peumans</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac (alpha 2&#x2013;6) Gal/GalNAc sequence</article-title>
          <source>J Biol Chem</source>
          <year>1987</year>
          <volume>262</volume>
          <fpage>1596</fpage>
          <lpage>1601</lpage>
          <pub-id pub-id-type="pmid">3805045</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vijayan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Surolia</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Imparting equisite specificity to peanut agglutinin for the tumor-associated Thomsen-Friedenreich antigen by redesign of its combining site</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>1209</fpage>
          <lpage>21213</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.271.2.1209</pub-id>
          <pub-id pub-id-type="pmid">8557652</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Polyvalency of Tn (GalNAc&#x3B1;&#xA0;&#x2192;&#xA0;Ser/Thr) glycotope as a critical factor for <italic>Vicia villosa</italic> B4 and glycoprotein interactions</article-title>
          <source>FEBS Lett</source>
          <year>2004</year>
          <volume>562</volume>
          <fpage>51</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-5793(04)00180-2</pub-id>
          <pub-id pub-id-type="pmid">15044001</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taketa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ichikawa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Datura stramonium</italic> agglutinin-reactive alpha-fetoprotein isoforms in hepatocellular carcinoma and other tumors</article-title>
          <source>Tumour Biol</source>
          <year>1990</year>
          <volume>11</volume>
          <fpage>220</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="doi">10.1159/000217658</pub-id>
          <pub-id pub-id-type="pmid">1695389</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Codina</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bastida</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Viladomat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Biodiversity of mannose-specific lectins within <italic>Narcissus</italic> species</article-title>
          <source>J Agric Food Chem</source>
          <year>2002</year>
          <volume>50</volume>
          <fpage>2507</fpage>
          <lpage>2513</lpage>
          <pub-id pub-id-type="doi">10.1021/jf011459v</pub-id>
          <pub-id pub-id-type="pmid">11958613</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pusztai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grant</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>RJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Kidney bean lectin-induced <italic>Escherichia coli</italic> overgrowth in the small intestine is blocked by GNA, a mannose-specific lectin</article-title>
          <source>J Appl Bacteriol</source>
          <year>1993</year>
          <volume>75</volume>
          <fpage>360</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">8226393</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
